These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29851941)

  • 1. Notes from the Field: Outbreak of Severe Illness Linked to the Vitamin K Antagonist Brodifacoum and Use of Synthetic Cannabinoids - Illinois, March-April 2018.
    Moritz E; Austin C; Wahl M; DesLauriers C; Navon L; Walblay K; Hendrickson M; Phillips A; Kerins J; Pennington AF; Lavery AM; El Zahran T; Kauerauf J; Yip L; Thomas J; Layden J
    MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(21):607-608. PubMed ID: 29851941
    [No Abstract]   [Full Text] [Related]  

  • 2. Brodifacoum-contaminated synthetic marijuana: clinical and radiologic manifestations of a public health outbreak causing life-threatening coagulopathy.
    Panigrahi B; Jones BC; Rowe SP
    Emerg Radiol; 2018 Dec; 25(6):715-718. PubMed ID: 30022308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bad weed: synthetic cannabinoid-associated coagulopathy.
    Arepally GM; Ortel TL
    Blood; 2019 Feb; 133(9):902-905. PubMed ID: 30655273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois.
    Kelkar AH; Smith NA; Martial A; Moole H; Tarantino MD; Roberts JC
    N Engl J Med; 2018 Sep; 379(13):1216-1223. PubMed ID: 30280655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Outbreak of Brodifacoum Coagulopathy Due to Synthetic Marijuana in Central Illinois.
    Hussain N; Hussain F; Haque D; Saeed S; Jesudas R
    Mayo Clin Proc; 2018 Jul; 93(7):957-958. PubMed ID: 29976379
    [No Abstract]   [Full Text] [Related]  

  • 6. Brodifacoum Poisoning Linked to Synthetic Marijuana Use in Wisconsin.
    Kircher M; Perez J
    WMJ; 2020 Jun; 119(2):129-131. PubMed ID: 32659068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Cannabinoid-Associated Coagulopathy: Case Report.
    Micula-Gondek W; Ruales V; Zorn C; Angelino A
    Psychosomatics; 2019; 60(2):211-215. PubMed ID: 30104022
    [No Abstract]   [Full Text] [Related]  

  • 8. Adherence to Long-Term Follow-Up of Patients with Life-Threatening, Inhaled Synthetic Cannabinoids-Associated Coagulopathy in Chicago.
    Tole M; LaBedz S; Feinstein DL; Rubinstein I
    Lung; 2019 Jun; 197(3):349-352. PubMed ID: 31004190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outbreak of synthetic cannabinoid exposures reported to a regional poison center: "K2" identified as 5F-ADB.
    Arens AM; Olives TD; Simpson NS; Laes JR; Anderson DL; Bangh SA; Lee SC; Martin S; Banister SD; Gerona RR; Cole JB
    Clin Toxicol (Phila); 2019 Jan; 57(1):69-71. PubMed ID: 30430881
    [No Abstract]   [Full Text] [Related]  

  • 10. Notes from the Field: Acute Poisonings from a Synthetic Cannabinoid Sold as Cannabidiol - Utah, 2017-2018.
    Horth RZ; Crouch B; Horowitz BZ; Prebish A; Slawson M; McNair J; Elsholz C; Gilley S; Robertson J; Risk I; Hill M; Fletcher L; Hou W; Peterson D; Adams K; Vitek D; Nakashima A; Dunn A
    MMWR Morb Mortal Wkly Rep; 2018 May; 67(20):587-588. PubMed ID: 29795081
    [No Abstract]   [Full Text] [Related]  

  • 11. Case of brodifacoum-contaminated synthetic cannabinoid.
    Riley SB; Sochat M; Moser K; Lynch KL; Tochtrop R; Isbell TS; Scalzo A
    Clin Toxicol (Phila); 2019 Feb; 57(2):143-144. PubMed ID: 30148410
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiological findings in poisoning by synthetic cannabinoids adulterated with brodifacoum.
    Bar N; Lopez-Alonso R; Merhav G; Naaman E; Leiderman M; Ilivitzki A; Lurie Y; Kurnik D; Abadi S
    Eur Radiol; 2024 Jul; 34(7):4540-4549. PubMed ID: 38127072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathic hemorrhage with use of synthetic cannabinoids.
    Boyack I; Opsha O
    Am J Emerg Med; 2019 Feb; 37(2):374.e3-374.e4. PubMed ID: 30409461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.
    Kasper AM; Ridpath AD; Arnold JK; Chatham-Stephens K; Morrison M; Olayinka O; Parker C; Galli R; Cox R; Preacely N; Anderson J; Kyle PB; Gerona R; Martin C; Schier J; Wolkin A; Dobbs T
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1121-2. PubMed ID: 26447715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An outbreak of severe coagulopathy in northern Israel among users of illicit synthetic cannabinoids adulterated with brodifacoum.
    Lurie Y; Nadir Y; Hoffman R; Miller A; Efrati E; Ring G; Sonenfeld D; Bar N; Zaidani H; Strizevsky A; Asali M; Lavon O; Kurnik D
    Clin Toxicol (Phila); 2023 Jun; 61(6):429-435. PubMed ID: 37293741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrhagic Soft Tissue Upper Airway Obstruction From Brodifacoum-Contaminated Synthetic Cannabinoid.
    Ross CH; Singh P; Simon EL
    J Emerg Med; 2019 Jul; 57(1):47-50. PubMed ID: 31078349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Public Health Response to a Large Poisoning Outbreak Involving an Illicit Substance: Synthetic Cannabinoids Contaminated With a Long-Acting Anticoagulant Rodenticide, Illinois, March-July, 2018.
    Navon L; Moritz E; Austin C; Wahl M; Aks S; Layden J
    J Public Health Manag Pract; 2020; 26(6):E1-E7. PubMed ID: 30969282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy After Synthetic Cannabinoid Use: A Case Report.
    Rasin A; Devgun JM; Nosal DG; Meehan TJ; van Breemen RB; Thompson TM
    Ann Intern Med; 2019 Oct; 171(8):595-596. PubMed ID: 31450243
    [No Abstract]   [Full Text] [Related]  

  • 19. Symptomatic brodifacoum ingestion requiring high-dose phytonadione therapy.
    Sheen SR; Spiller HA; Grossman D
    Vet Hum Toxicol; 1994 Jun; 36(3):216-7. PubMed ID: 8066968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
    Rubinstein I; van Breemen R; Nosal DG; Weinberg G; Hershow RC; Feinstein DL
    Drugs R D; 2019 Mar; 19(1):67-71. PubMed ID: 30689138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.